Non-alcoholic fatty liver disease: a practical approach to diagnosis and staging
Non-alcoholic fatty liver disease (NAFLD) is now the commonest cause of abnormal liver
function tests (LFTs) in the UK with approximately a third of the population being affected …
function tests (LFTs) in the UK with approximately a third of the population being affected …
Primary sclerosing cholangitis
Primary sclerosing cholangitis is a rare, chronic cholestatic liver disease characterised by
intrahepatic or extrahepatic stricturing, or both, with bile duct fibrosis. Inflammation and …
intrahepatic or extrahepatic stricturing, or both, with bile duct fibrosis. Inflammation and …
[HTML][HTML] Colorectal cancer in inflammatory bowel disease: what is the real magnitude of the risk?
The association between inflammatory bowel disease (IBD) and colorectal cancer (CRC)
has been recognised since 1925 and still accounts for 10%-15% of deaths in IBD. IBD …
has been recognised since 1925 and still accounts for 10%-15% of deaths in IBD. IBD …
Hepatocellular cancer: the impact of obesity, type 2 diabetes and a multidisciplinary team
J Dyson, B Jaques, D Chattopadyhay, R Lochan… - Journal of …, 2014 - Elsevier
Background & Aims Hepatocellular cancer (HCC) commonly complicates chronic liver
disease and increases in incidence have been reported despite falling prevalences of viral …
disease and increases in incidence have been reported despite falling prevalences of viral …
The British Society of Gastroenterology/UK-PBC primary biliary cholangitis treatment and management guidelines
GM Hirschfield, JK Dyson, GJM Alexander… - Gut, 2018 - gut.bmj.com
Primary biliary cholangitis (formerly known as primary biliary cirrhosis, PBC) is an
autoimmune liver disease in which a cycle of immune mediated biliary epithelial cell injury …
autoimmune liver disease in which a cycle of immune mediated biliary epithelial cell injury …
British Society of Gastroenterology and UK-PSC guidelines for the diagnosis and management of primary sclerosing cholangitis
MH Chapman, D Thorburn, GM Hirschfield… - Gut, 2019 - gut.bmj.com
These guidelines on the management of primary sclerosing cholangitis (PSC) were
commissioned by the British Society of Gastroenterology liver section. The guideline writing …
commissioned by the British Society of Gastroenterology liver section. The guideline writing …
Disease burden and costs from excess alcohol consumption, obesity, and viral hepatitis: fourth report of the Lancet Standing Commission on Liver Disease in the UK
R Williams, G Alexander, I Armstrong, A Baker, N Bhala… - The Lancet, 2018 - thelancet.com
This report contains new and follow-up metric data relating to the eight main
recommendations of the Lancet Standing Commission on Liver Disease in the UK, which …
recommendations of the Lancet Standing Commission on Liver Disease in the UK, which …
Novel therapeutic targets in primary biliary cirrhosis
Primary biliary cirrhosis (PBC) is a chronic immune-mediated liver disease characterized by
progressive cholestasis, biliary fibrosis and eventually cirrhosis. It results in characteristic …
progressive cholestasis, biliary fibrosis and eventually cirrhosis. It results in characteristic …
The new epidemiology of primary biliary cirrhosis
Primary biliary cirrhosis (PBC) is an autoimmune cholestatic liver disease. Susceptibility to
PBC probably arises from a combination of genetic and environmental factors. The …
PBC probably arises from a combination of genetic and environmental factors. The …
[HTML][HTML] Liver toxicity associated with sofosbuvir, an NS5A inhibitor and ribavirin use
Hepatitis C virus (HCV) infection is a major cause of end-stage liver disease and
hepatocellular carcinoma. There have been rapid advances in HCV treatment with the …
hepatocellular carcinoma. There have been rapid advances in HCV treatment with the …